UnitedHealth Group is rolling as one of the biggest winners in the Affordable Care Act era. The health insurer and services company posted significant first-quarter gains across all of its business lines.
Investors have flocked to publicly traded health insurers, as evidenced by soaring stocks so far in 2015. Optimism remains high in the sector even as signs emerge that medical costs are on the rise.
Medicare Advantage insurers last week learned the CMS will boost payment rates for 2016 by the highest amount since the ACA was enacted. Insurers have complained bitterly about the yearly rate uncertainty, but Advantage enrollment has grown by about 8% annually since 2010. What gives?
There have been numerous allegations of quality problems with Corizon's care, and since 2012, the company has lost contracts in Maine, Maryland, Minnesota, Pennsylvania and Tennessee worth more than $1.2 billion over the next five years.
Dr. Ronald DePinho, president of the University of Texas MD Anderson Cancer Center, a $4.4 billion Houston-based institution with a 654-bed flagship hospital and $736 million research budget, discusses the scientific promise and the financial problems in cancer care today.
Health insurer UnitedHealthcare is highlighting ICD-9 medical codes and quirky injuries in its first national consumer-facing ad campaign.
The Women-Inspired Neighborhood (WIN) Network, a Detroit-area collaboration between four regional health systems, partners systems with community organizations and local health departments to offer a comprehensive approach to addressing clinical and social factors associated with infant mortality.
Healthcare consumers have a new tool to compare prices using data from some of the largest U.S. health insurers, but comparison shopping will remain a challenge for most.
As more employers explore the advantages of self-insurance and administrative services only contracts, insurers have to find innovative ways to appeal to employers and help them reduce costs and improve care.
Two major private-sector players have launched a bundled-payment model for cancer care that could be a harbinger of more value-based payment arrangements in a wide range of clinical areas.
Two major players in the private sector have launched a fixed-payment structure for cancer care that could serve as a harbinger of more such arrangements as the appetite for such payment reforms continues to grow across the industry.
Our society loves the story of a “self-made” man, and even more the one who becomes a baron of industry.